Table 1 Clinicopathological background of patients with CRLM
Variables | n = 103 |
|---|---|
Age, year | 68 (35–84) |
Sex, M/F* | 61 (59.2) / 42 (40.8) |
Primary, Colon/Rectum | 65 (63.1) / 38 (36.9) |
Timing, synchronous/metachronous | 64 (62.1) / 39 (37.9) |
Child-Pugh classification, A/B/C | 95 (92.2) / 8 (7.8) / 0 (0.0) |
ICGR15, % | 8.7 (0.1–24.5) |
CEA, ng/ml | 9.4 (0.6–625.5) |
CA19–9, IU/ml | 21 (1–1400) |
Neoadjuvant chemotherapy | 44 (42.7) |
Adjuvant chemotherapy | 40 (38.8) |
Number of nodules | 3 (1–20) |
Maximum tumor diameter, cm | 2.4 (0.5–15.0) |
KRAS, wild type | 54 (56.8) |
Differentiation, well/mod/por | 21 (26.6) / 53 (67.1) / 5 (6.3) |